| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |